Intellectia LogoIntellectia
Stock
Crypto
Features
Resources
Company
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo
StockCrypto

Features

Pre Market Movers
Financial AI Agent
Swing Trading
Stock Technical Analysis
Stock Monitor
Copy Top Investors Portfolio
Crypto Technical Analysis
Chart Pattern Signal

Resources

Blog
Earnings
Partner Program

Company

Contact
About
News Release
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. CYCC

Stock Price & Analysis

-
stocks logo
CYCC
-
$
0.000
0.000(0%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

CYCC Stock Price Chart

5D
1M
3M
6M
YTD
1Y
5Y

CYCC Key Stats

High
Vol
Low
Amount
Open
VWAP
Mkt Cap

CYCC Company Profile

banner

CYCC Technical Analysis

Instant technical analysis with one click on any asset

banner

CYCC Why It Moves

Find out the reasons behind the current stock movement

banner

Should I Buy CYCC

AI-powered analysis to guide your buy, sell, or hold decision for this stock

banner

CYCC News Sentiment

AI uncovers potential trading opportunities based on news sentiment

banner

CYCC Technical Analysis

Instant technical analysis with one click on any asset

banner

CYCC Why It Moves

Find out the reasons behind the current stock movement

banner

Should I Buy CYCC

AI-powered analysis to guide your buy, sell, or hold decision for this stock

banner

CYCC News Sentiment

AI uncovers potential trading opportunities based on news sentiment

CYCC Fundamental Analysis

Moderate Buy
Buy
Hold
Sell
bubble
High
bubble
Averages
bubble
Low
Analyst
Rating
Action
Price Target
Date
Rating Reason

CYCC News

CYCC FAQs

What is surpport and resistant level for CYCC Stock?

The S1 support level for CYCC Stock is $0.33 ,The R1 resistant level for CYCC Stock is $0.4.

What is the current price of CYCC Stock?

As of the end of day on 2025-02-04, the price of CYCC Stock was $0.35.

What is the market cap of Cyclacel Pharmaceuticals Inc?

The market cap of CYCC is $3.9M.

What is Cyclacel Pharmaceuticals Inc (CYCC)'s business?

Cyclacel Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing cancer medicines based on cell cycle, transcriptional regulation and mitosis control biology. The transcriptional regulation program is evaluating fadraciclib, a Cyclin-dependent kinase 9 (CDK9) inhibitor, in solid tumors and hematological malignancies. The anti-mitotic program is evaluating plogosertib, a PLK1 inhibitor, in solid tumors and hematological malignancies. The Company's Mitosis Regulation program includes Plogosertib, which is a novel, small molecule, selective and potent Polo-like kinase 1 (PLK1) inhibitor. Plogosertib has demonstrated potent and selective target inhibition (PLK1 IC50 approximately 3 nM) and impressive efficacy in human tumor xenografts at non-toxic doses. Its translational biology program supports the development of plogosertib in acute leukemias and solid tumors.

How many employees does CYCC have?

CYCC has a total of 12 employees.

CYCC Key Stats

High
Vol
Low
Amount
Open
VWAP
Mkt Cap

CYCC Company Profile

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Product
PricingPre Market MoversFinancial AI AgentSwing TradingStock Technical AnalysisStock MonitorCopy Top Investors PortfolioCrypto Technical Analysis
Support
BlogEarningsTerms of UsePrivacy PolicySitemapPartner Program
Start for Free